Next Article in Journal
Composition and Nutrient Information of Non-Alcoholic Beverages in the Spanish Market: An Update
Next Article in Special Issue
Beneficial Effects of Pterocarpan-High Soybean Leaf Extract on Metabolic Syndrome in Overweight and Obese Korean Subjects: Randomized Controlled Trial
Previous Article in Journal
Effects of Phytoestrogen Extracts Isolated from Elder Flower on Hormone Production and Receptor Expression of Trophoblast Tumor Cells JEG-3 and BeWo, as well as MCF7 Breast Cancer Cells
Previous Article in Special Issue
Oral Administration of Fermented Soymilk Products Protects the Skin of Hairless Mice against Ultraviolet Damage
Open AccessArticle

The Effectiveness of a Bioactive Food Compound in the Lipid Control of Individuals with HIV/AIDS

1
Nutrition Service, University Hospital, Federal University of Mato Grosso do Sul—UFMS, Campo Grande 79079-900, MS, Brazil
2
Post Graduate Program in Health and Development in the Central-West Region of Brazil, Federal University of Mato Grosso do Sul—UFMS, Campo Grande 79079-900, MS, Brazil
*
Author to whom correspondence should be addressed.
Nutrients 2016, 8(10), 598; https://doi.org/10.3390/nu8100598
Received: 21 July 2016 / Revised: 9 September 2016 / Accepted: 19 September 2016 / Published: 8 October 2016
(This article belongs to the Special Issue Health Benefits of Soybean and other Grain Legumes)
Cardiovascular events due to decompensated lipid metabolism are commonly found in Human Immunodeficiency Virus/Acquired Immunodeficiency Syndrome (HIV/AIDS) patients using anti-retroviral therapy (HAART). Thus, the aim of this study was to identify the effect of a bioactive food compound (BFC) containing functional foods on individuals with HIV undergoing HAART. Particularly, this study aims to verify the clinical outcome in the change of the lipid profile due to the use of this compound. This study includes 115 individuals with HIV on HAART. All patients received dietary guidelines; however, sixty-one consumed BFC while fifty-one did not (NO BFC). Biochemical examinations and socio-demographic and clinical profiles were evaluated. As result, in patients using hypolipidemic and/or hypoglycemic drugs, there was 28.6% decrease in triglyceride levels (p < 0.001) in the NO BFC group, and 18.3% reduction in low density lipoprotein cholesterol (LDL-C) (p < 0.001) in the BFC group. In patients who did not use hypolipidemic and/or hypoglycemic drugs in the NO BFC group, there was 30.6% increase in triglycerides, 11.3% total cholesterol and 15.3% LDL-C levels (p < 0.001) while for the BFC group there was 4.5% reduction in total cholesterol (p < 0.001). In conclusion, this study evidenced that the dietary intervention containing BFC positively affected in lipid control, since these HIV/AIDS patients using HAART are more vulnerable to lipid disorders. View Full-Text
Keywords: lipid profile; anti-retroviral therapy; functional food; dyslipidemia; metabolic syndrome lipid profile; anti-retroviral therapy; functional food; dyslipidemia; metabolic syndrome
Show Figures

Figure 1

MDPI and ACS Style

Dos Santos Ferreira, R.; De Cássia Avellaneda Guimarães, R.; Jardim Cury Pontes, E.R.; Aragão do Nascimento, V.; Aiko Hiane, P. The Effectiveness of a Bioactive Food Compound in the Lipid Control of Individuals with HIV/AIDS. Nutrients 2016, 8, 598.

Show more citation formats Show less citations formats
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

1
Back to TopTop